Central serous chorioretinopathy after renal transplantation

Retina

Volumn 31, Issue 9, 2011, Pages 1896-1903

  Lee, Christopher Seungkyu ^a   Kang, Eui Chun ^a   Lee, Kyu Sung ^a   Byeon, Seok Ho ^a   Koh, Hyoung Jun ^a   Lee, Sung Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

central serous chorioretinopathy; management; steroid; transplantation

Indexed keywords

AMLODIPINE; ATENOLOL; AZATHIOPRINE; CANDESARTAN; CARVEDILOL; CREATININE; CYCLOSPORIN; DEFLAZACORT; DILTIAZEM; ENALAPRIL; EPROSARTAN; FELODIPINE; IRBESARTAN; LOSARTAN; MANIDIPINE; MIZORIBINE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; VALSARTAN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CATARACT; CENTRAL SEROUS RETINOPATHY; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; COLON CANCER; COLON RESECTION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ENDOMETRIUM CANCER; ENDOTAMPONADE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERTENSIVE NEPHROPATHY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR GAS TAMPONADE; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PERITONEAL DIALYSIS; PREDICTIVE VALUE; REMISSION; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; THYROID CANCER; THYROIDECTOMY; UTERINE CERVIX CANCER; VESICOURETERAL REFLUX; VISUAL ACUITY; VITRECTOMY;

ADULT; CENTRAL SEROUS CHORIORETINOPATHY; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDNISOLONE; PREGNENEDIONES; RETROSPECTIVE STUDIES; TIME FACTORS; VISUAL ACUITY;

EID: 80053349984     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31820a69ee     Document Type: Article

References (50)

1. Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 1997;41:180-185.
2. Bennett G. Central serous retinopathy. Br J Ophthalmol 1955; 39:605-618.
3. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63:S1-S139.
4. Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina 1987;7:111-131.
5. Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Am J Ophthalmol 1974;77:158-160.
6. Matsuo T, Nakayama T, Koyama T, Matsuo N. Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica 1987;195:97-102.
7. Gass JD. Bullous retinal detachment and multiple retinal pigment epithelial detachments in patients receiving hemodialysis. Graefes Arch Clin Exp Ophthalmol 1992;230:454-458.
8. Suzuki Y, Kogure M, Kato M. A case of multifocal posterior pigment epitheliopathy following renal transplantation. Ganka Rinso Iho 1986;80:212-214.
9. Fawzi AA, Holland GN, Kreiger AE, et al. Central serous chorioretinopathy after solid organ transplantation. Ophthalmology 2006;113:805-813, e805.
10. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002;47:431-448.
11. Friberg TR, Eller AW. Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefes Arch Clin Exp Ophthalmol 1990;228:305-309.
12. Gass JD, Slamovits TL, Fuller DG, Gieser RG, Lean JS. Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol 1992;110:1717-1722.
13. Polak BC, Baarsma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1995;79:922-925.
14. Lazowski P, Sablay LB, Glicklich D. Recurrent crescentic membranous nephropathy in two successive renal transplants: Association with choroidal effusions and retinal detachment. Am J Nephrol 1998;18:146-150.
15. Iida T, Spaide RF, Haas A, et al. Leopard-spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol 2002;120:37-42.
16. Singh AD, Demirci H, Shields CL, Shields JA. Central serous chorioretinopathy as a complication of postcardiac transplant corticosteroid therapy. Eye 2003;17:522-524.
17. Scorolli L, Giardina D, Morara M, Corazza D, Meduri RA. Bilateral serous retinal detachments following organ transplantation. Retina 2003;23:785-791.
18. Oliaei F, Rasoulinejad A, Seifi B. An ophthalmological complication: Central serous chorioretinopathy in a renal transplant recipient. Transplant Proc 2007;39:1134-1135.
19. Rasouli M, Leung D, Gale JS. A unique presentation of bilateral central serous chorioretinopathy following bilateral renal transplantation surgery. Can J Ophthalmol 2008;43:486-488.
20. MoonSJ,MielerWF.Retinalcomplicationsofbonemarrowandsolid organ transplantation. Curr Opin Ophthalmol 2003;14:433-442.
21. Gass JD.Diagnosis and Treatment. 4th ed. St. Louis, MO: Mosby; 1997.
22. Otsuka S, Ohba N, Nakao K. A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina 2002; 22:25-32.
23. Sahu DK, Namperumalsamy P, Hilton GF, de Sousa NF. Bullous variant of idiopathic central serous chorioretinopathy. Br J Ophthalmol 2000;84:485-492.
24. Nayak S, Acharjya B. Deflazacort versus other glucocorticoids: A comparison. Indian J Dermatol 2008;53:167-170.
25. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg 1997;13:388-391.
26. Song E, Wakakura M, Ishikawa S. Central serous chorioretinopathy induced by corticosteroids [in Japanese]. Nippon Ganka Gakkai Zasshi 1997;101:257-264.
27. Bouzas EA, Moret P, Pournaras CJ. Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids. Graefes Arch Clin Exp Ophthalmol 1999;237:166-168.
28. Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002;109:1834-1837.
29. Cusani M. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2004;49:128-129, author reply 129.
30. Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 1995;102:737-747.
31. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Risk factors for central serous chorioretinopathy: A case-control study. Ophthalmology 2004;111:244-249.
32. Harada T, Harada K. Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol 1985;60:37-44.
33. Iida T, Spaide RF, Negrao SG, Carvalho CA, Yannuzzi LA. Central serous chorioretinopathy after epidural corticosteroid injection. Am J Ophthalmol 2001;132:423-425.
34. Karadimas P, Kapetanios A, Bouzas EA. Central serous chorioretinopathy after local application of glucocorticoids for skin disorders. Arch Ophthalmol 2004;122:784-786.
35. Spraul CW, Lang GE, Lang GK. Retinal pigment epithelial changes associated with systemic corticosteroid treatment: Report of cases and review of the literature. Ophthalmologica 1998;212:142-148.
36. KlaisCM, OberMD, Ciardella AP, Yannuzzi LA. Central Serous Chorioretinopathy. 4th ed. St. Louis, MO: Mosby; 2006:63.
37. Spaide RF. Central Serous Chorioretinopathy and Other Causes of Serous Detachment of the Retina. Philadelphia, PA: W. B. Saunders; 1999:241.
38. Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandra S. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol 1974;91:247-250.
39. Brancato R, Scialdone A, Pece A, Coscas G, Binaghi M. Eightyear follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol 1987; 225:166-168.
40. Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 1989;96:854-859.
41. Loo RH, Scott IU, Flynn HW Jr., et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002; 22:19-24.
42. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231-242.
43. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34.
44. Karpik AG, Schwartz MM, Dickey LE, Streeten BW, Roberts JL. Ocular immune reactants in patients dying with systemic lupus erythematosus. Clin Immunol Immunopathol 1985;35: 295-312.
45. Cunningham ET Jr., Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology 1996;103:2081-2090.
46. Bouzas E, Mastorakos G. Central serous retinopathy in systemic lupus erythematosus: A manifestation of the disease or of its treatment? Br J Ophthalmol 1994;78:420-421.
47. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: Fluorescein angiographic findings. Ophthalmologica 1982;185:168-178.
48. Avci R, Deutman AF. The Treatment of Serous Choroidopathy with a Beta-Blocker; Metoprolol [in German]. Klin Monatsbl Augenheilkd 2005;202:199-205.
49. Chrapek O, Spackova K, Rehak J. Treatment of central serous chorioretinopathy with beta blockers[in Czech]. Cesk Slov Oftalmol 2002;58:382-386.
50. Fabianova J, Porubska M, Cepilova Z. Central serous chorioretinopathy- treatment with beta blockers[in Slovak]. Cesk Slov Oftalmol 1998;54:401-404.